GM2A Back

GM2 ganglioside activator

External References:      Wikipedia GeneCards HUGO COSMIC Google Scholar

NCBI Description of GM2A

This gene encodes a small glycolipid transport protein which acts as a substrate specific co-factor for the lysosomal enzyme beta-hexosaminidase A. Beta-hexosaminidase A, together with GM2 ganglioside activator, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Mutations in this gene result in GM2-gangliosidosis type AB or the AB variant of Tay-Sachs disease. Alternative splicing results in multiple transcript variants.

Community Annotation of GM2A Add / Edit GM2A: Annotations

No community annotations yet for GM2A.
Sort mutations by: Tumor type  Mutation type  Position  
Straightedge cursor Expand

Figure notes


• "Mouse over" a mutation to see details.
• Missense green saturation indicates evolutionary conservation of the mutated positions.
• Red hashes in protein strip are splice sites.
• Blue-white-red bars are log2 copy ratio distributions (–1 to +1) from Zack et al. (2013).


Legend

GM2A is highly significantly mutated in
(none)
GM2A is significantly mutated in
(none)
GM2A is near significance in
(none)

Click on a tumor type to see its full list of significant genes.

Data details


Mutation list for GM2A